Diagnostic centres carry heavy fixed cost in equipment and space. Drapto measures revenue per test and per centre, tracks which referral sources actually send paying work, and keeps collections from ageing quietly.
Capital equipment does not fail on price. It fails on volume.
The business case for a scanner is almost always built on an assumed number of scans per month. Whether that assumption held is the single most important thing to measure afterwards — and the thing least often tracked.
Test-level revenue shows which modalities carry the centre and which are quietly subsidised. Referral source attribution shows who is actually sending work that gets paid for.
Diagnostic work frequently sits on corporate accounts and insurer balances that quietly slide past ninety days. Ageing buckets and collection efficiency by centre stop that becoming a write-off conversation.
Break-even modelling before purchase, and utilisation measurement afterwards, turns capital spend into a tested assumption.
Knowing which referrers send work that actually gets paid changes who you invest relationship time in.
Ageing visibility catches slow-paying accounts before the balance reaches the low-recovery band.
Multi-centre operators can see which site is genuinely performing rather than which one reports most optimistically.
Drapto sits alongside your operational and reporting systems. It reads financial and operational outcomes rather than handling image acquisition or reporting workflow.
Yes. The free break-even calculator models contribution margin, break-even volume and payback with a realistic ramp period.
Yes. Referring doctors, corporate accounts and walk-ins are treated as distinct sources measured on revenue produced.
Yes, with identical definitions across centres so comparison is direct.